Peter Holleman
28-09-2021
The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.
Back to newsMore news
Collaboration for future-proof diagnostics and to accelerate research
02-05-2023
Complete analysis of the DNA of children with cancer offers many possibilities. It maps out all possible targeted treatment options …
In search of the optimal treatment strategy for glioblastoma
30-05-2023
Patients with recurrent glioblastoma have an unfavorable outlook and few treatment options. The recently launched GLOW study should change this …
Whole Genome Sequencing for cancer diagnostics clinically validated
18-05-2021
Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …
WGS is a helpful addition to our toolbox, alongside the classic HE, IHC and the (broad) NGS panels and should ideally be available in every regional oncology network
Head of the Pathology department, Leiden University Medical Center (LUMC)
